Capacity Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Capacity Bio General Information

Description

Developer of a mitophagy therapeutic platform intended to improve mitochondrial quality and function in disease research and drug development. The company offers small molecules, peptides, nanoparticles, and analytical tools for identifying dysfunctional mitochondria, activating mitophagy pathways, and measuring mitochondrial characteristics, enabling biotechnology researchers and drug developers working on neurodegenerative, autoimmune, muscular, and genetic orphan indications to study mitochondrial biology and advance preclinical therapeutic programs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 570 Westwood Plaza
  • Building 114
  • Los Angeles, CA 90095
  • United States
+1 (310)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 570 Westwood Plaza
  • Building 114
  • Los Angeles, CA 90095
  • United States
+1 (310)

Capacity Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Capacity Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Nov-2023 Completed Pre-Clinical Trials
2. Early Stage VC 31-Mar-2023 $35M $54.2M Completed Pre-Clinical Trials
1. Seed Round 17-Jan-2023 $19.2M $19.2M Completed Pre-Clinical Trials
To view Capacity Bio’s complete valuation and funding history, request access »

Capacity Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Capacity Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Capacity Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a mitophagy therapeutic platform intended to improve mitochondrial quality and function in disease research
Drug Discovery
Los Angeles, CA
10 As of 2024

Needham, MA
 

San Carlos, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Capacity Bio Competitors (3)

One of Capacity Bio’s 3 competitors is Mighty Therapeutics, a Private Equity-Backed company based in Needham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mighty Therapeutics Private Equity-Backed Needham, MA
Acurex Biosciences Venture Capital-Backed San Carlos, CA
Mitochon Pharmaceuticals Venture Capital-Backed Blue Bell, PA
You’re viewing 3 of 3 competitors. Get the full list »

Capacity Bio Patents

Capacity Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026041086-A1 Mas agonists and processes of making thereof Pending 22-Aug-2024
AU-2022212113-A1 Methods and agents that stimulate mitochondrial turnover for treating disease Pending 28-Jan-2021
CA-3209749-A1 Methods and agents that stimulate mitochondrial turnover for treating disease Pending 28-Jan-2021
EP-4284779-A1 Methods and agents that stimulate mitochondrial turnover for treating disease Pending 28-Jan-2021
EP-4284779-A4 Methods and agents that stimulate mitochondrial turnover for treating disease Pending 28-Jan-2021 A61K31/4178
To view Capacity Bio’s complete patent history, request access »

Capacity Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Capacity Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Magnify Accelerator/Incubator
AN Venture Partners Venture Capital Minority
RA Capital Management Asset Manager Minority
Remiges Ventures Venture Capital Minority
To view Capacity Bio’s complete investors history, request access »

Capacity Bio FAQs

  • When was Capacity Bio founded?

    Capacity Bio was founded in 2021.

  • Where is Capacity Bio headquartered?

    Capacity Bio is headquartered in Los Angeles, CA.

  • What is the size of Capacity Bio?

    Capacity Bio has 10 total employees.

  • What industry is Capacity Bio in?

    Capacity Bio’s primary industry is Drug Discovery.

  • Is Capacity Bio a private or public company?

    Capacity Bio is a Private company.

  • What is Capacity Bio’s current revenue?

    The current revenue for Capacity Bio is .

  • How much funding has Capacity Bio raised over time?

    Capacity Bio has raised $54.2M.

  • Who are Capacity Bio’s investors?

    Magnify, AN Venture Partners, RA Capital Management, and Remiges Ventures have invested in Capacity Bio.

  • Who are Capacity Bio’s competitors?

    Mighty Therapeutics, Acurex Biosciences, and Mitochon Pharmaceuticals are competitors of Capacity Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process